Long-term Follow-up: Daclatasvir-based Regimens for HCV Long-term Follow-up: Daclatasvir-based Regimens for HCV

This study evaluated the long-term outcomes and safety of daclatasvir-based regimens for chronic HCV infection administered during clinical trials.Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news